Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00634153 · ClinicalTrials.gov registry record
The Surgical Gastrointestinal Diseases Registry Protocol
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 750
- Enrollment target
NCT00634153: Completed study, sponsored by University of Pittsburgh.
NCT00634153 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 750 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00634153 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 750 participants
- Enrollment target
Study Summary
By placing the medical record information of many subjects into a research registry, researchers will be able to conduct research studies directed at increasing our knowledge about Gastrointestinal Diseases.
Interventions
- OTHER Research Registry
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 750 participants |
| Start Date | 2004-01 |
| Est. Completion | 2018-01-30 |
What the finished NCT00634153 record still lists
NCT00634153 is an observational study that tracks outcomes without assigning an intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Research Registry is the first listed.
NCT00634153 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00634153 about?
NCT00634153 is a clinical study titled "The Surgical Gastrointestinal Diseases Registry Protocol". By placing the medical record information of many subjects into a research registry, researchers will be able to conduct research studies directed at increasing our knowledge about Gastrointestinal Diseases.
What is the current status of trial NCT00634153?
This trial is currently completed. The enrollment target is 750 participants. The study started on 2004-01. Estimated completion is 2018-01-30.
What interventions are being tested in trial NCT00634153?
The interventions under investigation include: Research Registry (OTHER).
Who is sponsoring clinical trial NCT00634153?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02048332 · 750 participants · Phase 1
Donor-Derived Viral Specific T-cells (VSTs)
- NCT02087852 · 750 participants
Kidney Cancer DNA Registry
- NCT02532452 · 750 participants · Phase 2
Third Party Viral Specific T-cells (VSTs)
- NCT03126916 · 750 participants · Phase 3
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia